Affinimark is Diagnostic Equipment in United States that focus on testing options business. Founded in 2007. They cover business area such as developer, medical diagnostic product, timely diagnosis, treatment, patient, science, experience, an insatiable desire, good standard, care, current practice, diagnostic testing option, early-stage prostate cancer, cerebrospinal fluid leak surgery, their disease.
2007
( 17 years old in 2024 )
Testing Options
-
Post Office Box 122
Guilford, CT 06437
United States
Private
developermedical diagnostic producttimely diagnosistreatmentpatientscienceexperiencean insatiable desiregood standardcarecurrent practicediagnostic testing optionearly-stage prostate cancercerebrospinal fluid leak surgerytheir disease
* We use standard office opening hours in near Affinimark's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Affinimark is Diagnostic Equipment business from United States that founded in 2007 (17 years old in 2024), Affinimark business is focusing on Testing Options.
Affinimark headquarter office and corporate office address is located in Post Office Box 122 Guilford, CT 06437 United States.
Affinimark was founded in United States.
In 2024, Affinimark is currently focus on testing options sector.
Above is snippet of Google Trends for "testing options" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Affinimark, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.